Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer
Author:
Funder
National Research Foundation of Korea
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference21 articles.
1. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis;Petrelli;Gynecol. Oncol.,2014
2. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery;Ferrandina;Gynecol. Oncol.,2010
3. Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study;Hequet;Eur. J. Surg. Oncol.,2013
4. The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer;Chereau;Anticancer Res.,2013
5. Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer?;Leguevaque;Eur. J. Obstet. Gynecol. Reprod. Biol.,2011
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging;Cancer Biotherapy and Radiopharmaceuticals;2024-06-03
2. Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer;Biochemical Genetics;2024-04-08
3. Retrospective Analysis on the Need for Surgery for Residual Disease after Chemoradiation in Carcinoma Cervix;Journal of South Asian Federation of Obstetrics and Gynaecology;2023-09-16
4. Anticancer action of naturally occurring emodin for the controlling of cervical cancer;Exploration of Targeted Anti-tumor Therapy;2023-08-31
5. CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer;Journal of Molecular Histology;2023-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3